These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28431962)

  • 21. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents.
    Gou Y; Li J; Fan B; Xu B; Zhou M; Yang F
    Eur J Med Chem; 2017 Jul; 134():207-217. PubMed ID: 28415010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Copper in diseases and treatments, and copper-based anticancer strategies.
    Tisato F; Marzano C; Porchia M; Pellei M; Santini C
    Med Res Rev; 2010 Jul; 30(4):708-49. PubMed ID: 19626597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Redox-implications associated with the formation of complexes between copper ions and reduced or oxidized glutathione.
    Aliaga ME; López-Alarcón C; Bridi R; Speisky H
    J Inorg Biochem; 2016 Jan; 154():78-88. PubMed ID: 26277412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lights and shadows in the challenge of binding acyclovir, a synthetic purine-like nucleoside with antiviral activity, at an apical-distal coordination site in copper(II)-polyamine chelates.
    Pérez-Toro I; Domínguez-Martín A; Choquesillo-Lazarte D; Vílchez-Rodríguez E; González-Pérez JM; Castiñeiras A; Niclós-Gutiérrez J
    J Inorg Biochem; 2015 Jul; 148():84-92. PubMed ID: 25863571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of Dipyridyl Ketone Isonicotinoyl Hydrazone Copper(II) Complex: Structure, Anticancer Activity and Anticancer Mechanism.
    Deng J; Chen W; Deng H
    J Fluoresc; 2016 Nov; 26(6):1987-1996. PubMed ID: 27488686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro copper-chelating properties of flavonoids.
    Ríha M; Karlícková J; Filipský T; Jahodár L; Hrdina R; Mladenka P
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S46. PubMed ID: 26461386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes.
    Lovejoy DB; Jansson PJ; Brunk UT; Wong J; Ponka P; Richardson DR
    Cancer Res; 2011 Sep; 71(17):5871-80. PubMed ID: 21750178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of intrinsic and extrinsic apoptosis through oxidative stress in drug-resistant cancer by a newly synthesized Schiff base copper chelate.
    Banerjee K; Basu S; Das S; Sinha A; Biswas MK; Choudhuri SK
    Free Radic Res; 2016; 50(4):426-46. PubMed ID: 26733073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.
    Qi J; Liang S; Gou Y; Zhang Z; Zhou Z; Yang F; Liang H
    Eur J Med Chem; 2015; 96():360-8. PubMed ID: 25899339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel copper-based therapeutic agent for anti-inflammatory: synthesis, characterization, and biochemical activities of copper(II) complexes of hydroxyflavone Schiff bases.
    Joseph J; Nagashri K
    Appl Biochem Biotechnol; 2012 Jul; 167(5):1446-58. PubMed ID: 22238015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cuproptosis in cancers: Function and implications from bench to bedside.
    Huang XY; Shen JY; Huang K; Wang L; Sethi G; Ma Z
    Biomed Pharmacother; 2024 Jul; 176():116874. PubMed ID: 38850661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 8-hydroxyquinoline based neutral tripodal ionophore as a copper (II) selective electrode and the effect of remote substitutents on electrode properties.
    Mittal SK; Kumar A; Gupta N; Kaur S; Kumar S
    Anal Chim Acta; 2007 Feb; 585(1):161-70. PubMed ID: 17386661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipophilic ionophore complexes as superoxide dismutase mimetics.
    Fisher AE; Lau G; Naughton DP
    Biochem Biophys Res Commun; 2005 Apr; 329(3):930-3. PubMed ID: 15752745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox cycling of endogenous copper by ferulic acid leads to cellular DNA breakage and consequent cell death: A putative cancer chemotherapy mechanism.
    Sarwar T; Zafaryab M; Husain MA; Ishqi HM; Rehman SU; Rizvi MM; Tabish M
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):251-61. PubMed ID: 26415834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doubly chloro bridged dimeric copper(II) complex: magneto-structural correlation and anticancer activity.
    Sikdar Y; Modak R; Bose D; Banerjee S; Bieńko D; Zierkiewicz W; Bieńko A; Das Saha K; Goswami S
    Dalton Trans; 2015 May; 44(19):8876-88. PubMed ID: 25871579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative breakage of cellular DNA by plant polyphenols: a putative mechanism for anticancer properties.
    Hadi SM; Bhat SH; Azmi AS; Hanif S; Shamim U; Ullah MF
    Semin Cancer Biol; 2007 Oct; 17(5):370-6. PubMed ID: 17572102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-proliferative effects of copper(II) complexes with hydroxyquinoline-thiosemicarbazone ligands.
    Rogolino D; Cavazzoni A; Gatti A; Tegoni M; Pelosi G; Verdolino V; Fumarola C; Cretella D; Petronini PG; Carcelli M
    Eur J Med Chem; 2017 Mar; 128():140-153. PubMed ID: 28182987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copper(II) complexes of 1,10-phenanthroline-derived ligands: studies on DNA binding properties and nuclease activity.
    Hirohama T; Kuranuki Y; Ebina E; Sugizaki T; Arii H; Chikira M; Tamil Selvi P; Palaniandavar M
    J Inorg Biochem; 2005 May; 99(5):1205-19. PubMed ID: 15833344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LC-MS/MS and density functional theory study of copper(II) and nickel(II) chelating complexes of elesclomol (a novel anticancer agent).
    Wu L; Zhou L; Liu DQ; Vogt FG; Kord AS
    J Pharm Biomed Anal; 2011 Jan; 54(2):331-6. PubMed ID: 20933353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.